Finance

Lists
IBT-B:STO
Infant Bacterial Therapeutics AB
SEK 80,10
-1,84%
(-1,50) 1D
21 Okt., 10:28:17 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for IBT-B...
Open
SEK 81,50
High
SEK 81,60
Low
SEK 80,10
Mkt. cap
1,04 mjd
Avg. vol.
6,25 k
Volume
113,00
52-wk high
SEK 84,90
52-wk low
SEK 43,25
EPS
-SEK 6,08
Shares outstanding
13,02 m
No. of employees
6
Open
SEK 81,50
High
SEK 81,60
Low
SEK 80,10
Mkt. cap
1,04 mjd
Avg. vol.
6,25 k
Volume
113,00
52-wk high
SEK 84,90
52-wk low
SEK 43,25
EPS
-SEK 6,08
Shares outstanding
13,02 m
No. of employees
6
News stories
From web sources and news partners
About Infant Bacterial Therapeutics AB
CEOStaffan Strömberg
Employees6
Founded2011
Headquarters-
SectorPharmaceutical industry
Websiteibtherapeutics.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
6,01 m
15,66 m
18,69 m
23,02 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,83 m
4,88 m
4,81 m
7,09 m
Operating expense
10,84 m
20,54 m
23,50 m
30,11 m
Total operating expenses
10,84 m
20,54 m
23,50 m
30,11 m
Operating income
-10,84 m
-20,54 m
-23,50 m
-30,11 m
Other non operating income
1,00 k
-1,00 k
-563,44 m
-
EBT including unusual items
-10,05 m
-19,20 m
-22,94 m
-29,73 m
EBT excluding unusual items
-10,05 m
-19,20 m
-22,94 m
-29,73 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-10,05 m
-19,20 m
-22,94 m
-29,73 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
784,00 k
1,34 m
564,00 m
380,00 k
Interest expense
-
-
-
-
Net interest expenses
784,00 k
1,34 m
564,00 m
380,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme